Newsmeme!
Discover News you didn't know existed
Researchers have identified a previously unrecognized target, a protein called STAT3, at which they can aim new drugs for the treatment of cancer in neurofibromatosis-1 (NF1), a genetic condition that causes increased risk of benign and malignant brain tumors.
A Sparta couple credits their 51 years of marriage to the Lord and the strength they have gained through their belief in Him. Through Don Wooten's battle with cancer, he and wife Jolene "Jo," have come out of the battle stronger Christians, stronger individuals and a stronger couple.
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
( Washington University School of Medicine ) Researchers have identified a previously unrecognized target, a protein called STAT3, at which they can aim new drugs for the treatment of cancer in neurofibromatosis-1 (NF1), a genetic condition that causes increased risk of benign and malignant brain tumors.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, researchers are zeroing in on a workhorse protein called RSK. When activated, RSK is involved in cell survival, cell proliferation, cell enlargement and a rare disease called Carney complex.
When Eric and Liz Albers were married on May 23 last year, the last thing they wanted to be thinking about was cancer. But three days later they received the news that Eric indeed had a cancerous tumor in his right shoulder, Liz said.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Chicago Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.When activated, RSK is involved in cell survival, cell proliferation and cell enlargement.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Chicago Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.
( Loyola University Health System ) In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola researchers are zeroing in on a workhorse protein called RSK. When activated, RSK is involved in cell survival, cell proliferation, cell enlargement and a rare disease called Carney complex.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK. When activated, RSK is involved in cell survival, cell proliferation and cell enlargement. These properties contribute towards cancer progression, heart enlargement and tumors associated with ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |